Waverley Pharma Inc.
WAVE.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -291.90K | -523.80K | -694.60K | -1.63M | -1.66M |
| Total Depreciation and Amortization | 47.10K | 32.20K | 17.30K | 61.60K | 119.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.50K | 89.20K | 108.80K | 761.30K | 766.10K |
| Change in Net Operating Assets | -4.70K | 73.80K | 269.30K | 219.10K | -46.30K |
| Cash from Operations | -195.20K | -328.70K | -299.30K | -586.40K | -820.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 184.30K | 184.30K | -- | -- | -- |
| Cash Acquisitions | -601.10K | -601.10K | -448.40K | -448.50K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -416.80K | -416.80K | -448.40K | -448.50K | -- |
| Total Debt Issued | 956.30K | 1.13M | 1.21M | 1.62M | 1.12M |
| Total Debt Repaid | -26.70K | -18.50K | -9.90K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 678.30K | 810.00K | 877.40K | 1.19M | 825.70K |
| Foreign Exchange rate Adjustments | 4.40K | 4.40K | 4.40K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.90K | 69.10K | 134.20K | 152.40K | 5.30K |